	Harnessing Artificial Intelligence to Code a Decision-Making Aid for the Prostate Cancer Brachytherapy Multidisciplinary Meeting Using Retrieval-Augmented Generation. Cureus Gabriel A, Antonoglou G, Langley S, Gabriel J. PMID: 41835737 [PubMed - as supplied by publisher]
	Nutrient intake and renal cancer: molecular pathways and mechanistic insights into the protective role of dietary components. Front Nutr Chen P, Bi X, Tian R, Zhang Q. PMID: 41835382 [PubMed - as supplied by publisher]
	Safety, Efficacy, and Intermediateâ€‘Term Outcomes of CTâ€‘Guided Cryoablation of T1 Renal Cell Carcinoma: A Retrospective Singleâ€‘Center Study. J Belg Soc Radiol Frenoy L, Buyck PJ, Bonne L, Van Cleynenbreugel B, Albersen M, Maleux G. PMID: 41835323 [PubMed - as supplied by publisher]
	Functional and Oncological Outcomes of Novel Anterior, Retzius-Sparing, and Conventional Anterior Approaches in Robot-Assisted Radical Prostatectomy: A Comparative Cohort Study. Int J Urol Kazashi K, Washino S, Saito K, Oshiro H, Miyagawa T. PMID: 41834066 [PubMed - indexed for MEDLINE]
	Urinary Diversion-Specific Morbidity After Radical Cystectomy: A Ten-Year Institutional Experience. Cancer Med Hu X, Miao J, Huang Y, Yang Y, Zhang X, Wang Y, Qian L, Zhang D, Wei H. PMID: 41833997 [PubMed - indexed for MEDLINE]
	MicroRNAs in Penile Cancer: Challenges, Opportunities, and Translational Perspectives. Crit Rev Oncol Hematol Furuya TK, Carrasco AG, Uno M, Arruda GV, El Hayek KK, Alves MJ, Pontes J Jr, Chammas R, Murta CB. PMID: 41833893 [PubMed - as supplied by publisher]
	Progress and Challenges in CAR-T Cell Therapy for Bladder Cancer. Crit Rev Oncol Hematol Zhao K, Zhou Z, Ma X, Xiao X, Cheng L, Liu S, Wang W, Dong Z. PMID: 41833891 [PubMed - as supplied by publisher]
	Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer With Biparametric Versus Size-Selective Diffusion MRI. J Magn Reson Imaging Cheng H, Lu J, Liu M, Zhang W, Zhu J, Chen M, Wu D, Li C. PMID: 41833541 [PubMed - as supplied by publisher]
	A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer. Eur Urol Chapin BF, Smaldone M, Zurita AJ, Wang J, Cooperberg MR, Gleave M, Delacroix SE, Davis J, Pettaway C, Pisters L, Adibi M, Chery L, Papadopoulos J, Ward J, Gregg J, Navai N, Corn P, Subudhi SK, Logothetis C, Kuban D, Nguyen Q, Tang C, Choi S, Hoffman K, Lozano M, Elsheftawi M, Achim M, Zhao Y, Ramesh N, Sei E, Navin N, Nogueras Gonzalez GM, Wang X, Zhu K, Troncoso P, Zhang M, McGuire S, Aparicio AM. PMID: 41833492 [PubMed - as supplied by publisher]
	A simple scoring system for predicting inguinal lymph node involvement and survival in patients with penile squamous cell carcinoma. Urol Oncol Guo Y, Cai Z, Ornellas AA, Schwentner C, Geng JH, Chen D, Huang G, Chen B, Zhang X, Jiang X, Liu J, Tang Y, Chen Z, Li Z. PMID: 41833456 [PubMed - as supplied by publisher]
	Factors Associated With Testicular Cancer Risk Among New American Military Recruits During Wartime. Am J Mens Health Nelson DA, Hill OT, Skaggs SA, Brown WJ. PMID: 41833285 [PubMed - indexed for MEDLINE]
	Study of bladder cancer detection in standard white light versus AI-supported endoscopy-01 (RAISE-01) - Development and validation of an AI-based support tool. Int J Med Inform Hjort PB, Jensen JE, Jensen JB, Ernst A. PMID: 41833082 [PubMed - as supplied by publisher]
	A Feasibility Study of the Repurposing of Prazosin to Improve Treatment Outcomes in Men Receiving Radiotherapy for Prostate Cancer (MiniRaP-00). Prostate King LD, Christie D, Cehic D, Dare W, Chess-Williams R, Sellers D, McDermott C, McCarthy A, Anoopkumar-Dukie S. PMID: 41833070 [PubMed - as supplied by publisher]
	Preferences of healthcare providers regarding future follow-up care for breast, prostate, and colorectal cancer: A discrete choice experiment. Support Care Cancer Liemburg GB, Stegmann ME, Burgers JS, Berendsen AJ, Berger MY, Schröder CP, Korevaar JC, Brandenbarg D. PMID: 41832396 [PubMed - indexed for MEDLINE]
	Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targeting. EJNMMI Res Harbi E, Bilgin GB, Emmett L, Kendi AT, Orme JJ, Muniz M, Childs DS, Lucien F, Chaudhuri AA, Sartor O. PMID: 41832388 [PubMed - as supplied by publisher]
	Genomic landscape and precision therapy in prostate cancer: current status and future directions. NPJ Precis Oncol Ligon JA, Anand S, Singh S, Siddiqui JA, Henegan JC, Singh AP. PMID: 41832316 [PubMed - as supplied by publisher]
	Predicting aggressiveness of clear cell renal cell carcinoma via mri using artificial intelligence: implications for surgical planning in a retrospective multicenter study. Sci Rep Zhao J, Wang H, Liao R, Liu M, Cui Z, Jin B, Wang Y, Tang R. PMID: 41832286 [PubMed - as supplied by publisher]
	Refining prognostication in non-muscle-invasive bladder cancer: From clinical models to artificial intelligence. Urol Oncol Mardelli C, Bertail T, Tachibana I, Verhoest G, Mathieu R, Pradere B, Xylinas E, Roupret M, Margulis V, Bensalah K, Lotan Y, Khene ZE. PMID: 41832109 [PubMed - as supplied by publisher]
	Clinical utility of large language models in metastatic prostate cancer: A multicenter expert validation for decision support. Eur J Cancer Chen Y, He K, Qu W, Ma L, Su X, Liu X, Kang Z, Li F, Yan J, Wang Z, Li J, Li Z. PMID: 41831267 [PubMed - as supplied by publisher]
	Role of molecular testing in diagnosis of renal neoplasms. Semin Diagn Pathol Gilpatrick T, Sanchez NG, Greenland NY, Sirohi D. PMID: 41831250 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176836

Page 1 of 8842



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy